Chambal Fertilisers and Chemicals Limited

NSE:CHAMBLFERT.NS

565.25 (INR) • At close June 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2025 Q42025 Q32025 Q22025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Revenue 24,487.349,180.643,461.849,332.326,430.443,485.753,855.255,892.835,986.782,962.185,867.572,911.833,060.447,433.344,786.135,395.216,407.638,726.439,869.432,186.719,690.938,320.435,661.428,711.126,936.92228,072.125,081.122,114.5
Cost of Revenue 11,958.829,429.324,254.930,310.815,468.924,374.934,172.836,358.922,087.159,76863,118.852,06918,556.530,030.728,104.120,952.78,355.323,324.224,177.718,875.39,906.922,936.720,966.816,325.213,972.39918,204.916,081.713,559.7
Gross Profit 12,528.519,751.319,206.919,021.510,961.519,110.819,682.419,533.913,899.623,194.122,748.720,842.814,503.917,402.616,68214,442.58,052.315,402.215,691.713,311.49,78415,383.714,694.612,385.912,964.5239,867.28,999.48,554.8
Gross Profit Ratio 0.5120.4020.4420.3860.4150.4390.3650.3490.3860.280.2650.2860.4390.3670.3720.4080.4910.3980.3940.4140.4970.4010.4120.4310.4810.3510.3590.387
Reseach & Development Expenses 0000000000000000000000000000
General & Administrative Expenses 0000000000000000000000000000
Selling & Marketing Expenses 0000000000000000000000000000
SG&A 615.9012,137.912,323.710,077.312,263532.7539.812,296.416,015.217,804.514,465.612,06911,1268,857.18,174.55,598.8429.8437.2433.3676.5373.1471.3464.4596.9302.2400.8396.3
Other Expenses 012,802.30511.5629.4954.6817.689.4413.1228.6888.4147.5-280.5188.917374.9-581.5-112522.1274.3-705.274.3448.5258.3477.989-986766.4188.9
Operating Expenses 615.912,802.312,137.912,323.710,077.313,617.214,316.713,972.413,544.417,274.719,085.915,669.611,430.612,336.910,065.39,364.25,3018,146.38,989.98,117.76,787.29,291.49,885.38,641.69,209.4276,454.37,086.26,426.1
Operating Income 11,912.66,9497,0696,697.8884.27,006.66,183.35,561.5732.86,146.14,891.55,173.22,863.85,065.76,616.75,078.32,751.37,255.96,701.85,193.72,996.86,092.34,809.33,744.33,755.0963,412.91,913.22,128.7
Operating Income Ratio 0.4860.1410.1630.1360.0330.1610.1150.10.020.0740.0570.0710.0870.1070.1480.1430.1680.1870.1680.1610.1520.1590.1350.130.1390.1220.0760.096
Total Other Income Expenses Net -10,235.4876.2787.2109.4269.51,148.3445.8-403.6-668.9-974379.2-61.2261.41,040.1728.7444.82,794.8-433.9-77.3-591-1,519.2-977.7-929.8-1,033.4-2,656.591-1,027.2652.3152.1
Income Before Tax 1,677.27,825.27,856.26,807.21,153.76,641.95,811.55,157.963.94,945.44,0425,1123,334.76,105.87,345.45,523.15,546.16,8226,624.54,602.71,477.65,114.63,879.52,710.91,098.5052,385.72,565.52,280.8
Income Before Tax Ratio 0.0680.1590.1810.1380.0440.1530.1080.0920.0020.060.0470.070.1010.1290.1640.1560.3380.1760.1660.1430.0750.1330.1090.0940.0410.0850.1020.103
Income Tax Expense 374.12,481.22,492.62,675.3290.62,047.92,001.91,771.9-875.91,706.31,300.11,694.9896.71,754.12,287.71,709.9128.62,114.52,257.41,618.9-403285.371.31,066.5256.241747.7754.9730.6
Net Income 1,303.65,344.25,363.74,483.6967.84,594.13,809.73,386.49413,240.32,742.73,418.22,435.74,350.65,059.23,814.34,478.94,710.64,370.32,987.81,975.54,803.33,8261,657.1918.2381,611.11,814.71,558.2
Net Income Ratio 0.0530.1090.1230.0910.0370.1060.0710.0610.0260.0390.0320.0470.0740.0920.1130.1080.2730.1220.110.0930.10.1250.1070.0580.0340.0570.0720.07
EPS 3.2513.3413.3911.192.5111.049.158.142.267.796.598.215.8510.4512.169.1610.7611.3210.57.184.7511.549.193.982.213.884.363.74
EPS Diluted 3.2513.3413.3911.192.5111.049.158.142.267.796.598.215.8510.4512.169.1610.7611.3210.57.184.7511.549.193.982.213.884.363.74
EBITDA 1,642.7758,724.98,701.58,031.72,294.47,239.36,967.76,422.51,527.56,928.95,333.46,081.33,857.36,016.37,541.75,886.66,408.17,860.97,942.16,175.82,619.26,899.26,024.14,787.94,887.2562,594.32,900.62,916
EBITDA Ratio 0.0670.1770.20.1630.0870.1660.1290.1150.0420.0840.0620.0830.1170.1270.1680.1660.3910.2030.1990.1920.1330.180.1690.1670.1810.0920.1160.132